Education
About Us
Working with TipRanks
Follow Us
FluoroPharma Medical Inc (FPMI)
OTHER OTC:FPMI
FPMI Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume40.00K
Average Volume (3M)0.00
Market Cap
$6.85K
Enterprise ValueN/A
Total Cash (Recent Filing)$24.72K
Total Debt (Recent Filing)$5.82M
Price to Earnings (P/E)―
Beta-1.42
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding34,262,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FPMI FAQ
What was FluoroPharma Medical Inc’s price range in the past 12 months?
FluoroPharma Medical Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is FluoroPharma Medical Inc’s market cap?
FluoroPharma Medical Inc’s market cap is $6.85K.
When is FluoroPharma Medical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were FluoroPharma Medical Inc’s earnings last quarter?
Currently, no data Available
Is FluoroPharma Medical Inc overvalued?
According to Wall Street analysts FluoroPharma Medical Inc’s price is currently Overvalued.
Does FluoroPharma Medical Inc pay dividends?
FluoroPharma Medical Inc does not currently pay dividends.
What is FluoroPharma Medical Inc’s EPS estimate?
FluoroPharma Medical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does FluoroPharma Medical Inc have?
FluoroPharma Medical Inc has 34,262,000 shares outstanding.
What happened to FluoroPharma Medical Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of FluoroPharma Medical Inc?
Currently, no hedge funds are holding shares in FPMI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
FluoroPharma Medical Inc
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.
Technical Analysis
Scinai Immunotherapeutics
―
Dermata Therapeutics
―
Conduit Pharmaceuticals
―
Virax Biolabs Group Ltd. Class A
―
Azitra Inc
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.34% Other Institutional Investors
99.66% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---